Other Professional Titles
On The Web
Dr. Weinberger’s primary research focuses on fundamental principles of gene regulation, and, more specifically, on the regulatory "master circuits" that control HIV and human herpes viruses. His laboratory employs a coupled, computational-experimental approach that relies on quantitative, time-lapse fluorescence microscopy with mathematical modeling to study viral gene-expression circuits and expression "noise" at the single-cell level.
Before joining the Gladstone Institute of Virology and Immunology and UCSF in 2011, Dr. Weinberger was an Assistant Professor of Chemistry and Biochemistry at the University of California, San Diego. He has been named an Alfred P. Sloan Foundation Research Fellow and has won the W.M. Keck Foundation Research Excellence Award, the California HIV/AIDS Young Investigator Innovative Development Award, the Bill and Melinda Gates Grand Challenges Award, the NIH Director’s New Innovator Award, the NIH Avant-Garde Award (declined), and the NIH Director's Pioneer Award. He is the only individual ever to win the NIH Director's Pioneer, Avant-Garde, and New Innovator awards. Dr. Weinberger is a member of numerous scientific societies, was a Visiting Professor at Harvard Medical School, and serves on the Innovation Review Panel for the Bill and Melinda Gates Foundation.
Dr. Weinberger earned a bachelor’s degree in 1998 at the University of Maryland, College Park, where he studied physics and biology. He then spent a year at the Los Alamos National Laboratory as a Department of Energy Scholar in the Theoretical Biophysics and Biology Group. In 2004, he earned a PhD in biophysics from the University of California, Berkeley, where he was a Howard Hughes Medical Institute Predoctoral Fellow. Dr. Weinberger then received postdoctoral training at Princeton University as a Lewis Thomas Fellow, working with Drs. Thomas Shenk and David Botstein.
I came to Gladstone because of the exceptionally talented colleagues in HIV research. In my mind, Gladstone is a world leader in HIV molecular biology research because it encourages its scientists to take bold risks for the betterment of human health.